bpc-157 inflammation The Hidden Risks of BPC‑157: What Patients Need to Know About Contamination and Safety BPC-157 for Injury Recovery and
Description
Medication given this way is absorbed more slowly than if injected into a vein or taken by mouth (orally), sometimes over a period of 24 hours
A formal Phase 2 trial was completed in 2009, but over 15 years later, the results have never been published, another major red flag suggesting it failed to prove effective or safe
Take one per day
Disclaimer: The information found on this website is for informational purposes only
It is a 43-amino-acid peptide, larger than BPC-157, which makes it slightly more susceptible to structural changes in solution
